KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synaptics (SYNA) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Synaptics (SYNA) over the last 17 years, with Q4 2025 value amounting to -$4.1 million.

  • Synaptics' Change in Accured Expenses rose 8333.33% to -$4.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $26.0 million, marking a year-over-year increase of 16753.25%. This contributed to the annual value of $4.1 million for FY2025, which is 19534.88% up from last year.
  • As of Q4 2025, Synaptics' Change in Accured Expenses stood at -$4.1 million, which was up 8333.33% from -$31.6 million recorded in Q3 2025.
  • In the past 5 years, Synaptics' Change in Accured Expenses registered a high of $33.9 million during Q1 2025, and its lowest value of -$38.7 million during Q1 2022.
  • Over the past 5 years, Synaptics' median Change in Accured Expenses value was -$2.8 million (recorded in 2023), while the average stood at -$5.6 million.
  • As far as peak fluctuations go, Synaptics' Change in Accured Expenses plummeted by 328000.0% in 2023, and later skyrocketed by 99354.84% in 2025.
  • Over the past 5 years, Synaptics' Change in Accured Expenses (Quarter) stood at $31.1 million in 2021, then crashed by 151.45% to -$16.0 million in 2022, then skyrocketed by 91.25% to -$1.4 million in 2023, then plummeted by 1657.14% to -$24.6 million in 2024, then skyrocketed by 83.33% to -$4.1 million in 2025.
  • Its Change in Accured Expenses stands at -$4.1 million for Q4 2025, versus -$31.6 million for Q3 2025 and $27.8 million for Q2 2025.